[1]
|
J.-L. Vincent and E. Abraham, “The Last 100 Years of Sepsis,” American Journal of Respiratory and Critical Care Medicine, Vol. 173, No. 3, 2006, pp. 256-263.
doi:10.1164/rccm.200510-1604OE
|
[2]
|
S. Chatterjee, S. Todi, S. Sahu and M. Bhattacharyya, “Epidemiology of Severe Sepsis in India,” Critical Care, Vol. 13, Suppl. 1, 2009, p. 345.
|
[3]
|
L. A. Al-Gwaiz and H. H. Babay. The Diagnostic Value of Absolute Neutrophil Count, Band Count and Morphologic Changes of Neutrophils in Predicting Bacterial Infections,” Medical Principles and Practice, Vol. 16, No. 5, 2007, pp. 344-347. doi:10.1159/000104806
|
[4]
|
A. Nakamura, H. Wada, M. Ikejiri, T. Hatada, H. Sakurai, Y. Matsushima, J. Nishioka, K. Maruyama, S. Isaji, T. Takeda and T. Nobori, “Efficacy of Procalcitonin in the Early Diagnosis of Bacterial Infections in a Critical Care Unit,” Shock, Vol. 31, No. 6, 2009, pp. 586-591.
doi:10.1097/SHK.0b013e31819716fa
|
[5]
|
L. Simon, F. Gauvin, D. K. Amre, P. Saint-Louis and J. Lacroix. “Serum Procalcitonin and C-Reactive Protein Levels as Markers of Bacterial Infection: A Systematic Review and Meta-Analysis,” Clinical Infectious Diseases, Vol. 39, No. 2, 2004, pp. 206-217.
doi:10.1097/SHK.0b013e31819716fa
|
[6]
|
A. van de Vyver, E. F. Delport, M. Esterhuizen and R. Pool, “The Correlation between C-Reactive Protein and Toxic Granulation of Neutrophils in the Peripheral Blood,” South African Medical Journal, Vol. 100, No. 7, 2010, pp. 442-444.
|
[7]
|
P. Schuetz, W. Albrich, M. Christ-Crain, J. Chastre and B. Mueller, “Procalcitonin for Guidance of Antibiotic Therapy,” Expert Reviews in Anti Infectives Therapy, Vol. 8, No. 5, 2010, pp. 575-587. doi:10.1586/eri.10.25
|
[8]
|
P. Emmanuel Charles, E. Kus, S. Aho, S. Prin, J.-M. Doise, N.-O. Olsson, B. Blettery and J.-P. Quenot, “Serum Procalcitonin for the Early Recognition of Nosocomial Infection in the Critically Ill Patients: A Preliminary Report,” BMC Infectious Diseases, Vol. 9, No. 1, 2009, pp. 49-58.
|
[9]
|
J. U. Jensen, L. Heslet, T. H. Jensen, K. Espersen, P. Steffensen and M. Tvede, “Procalcitonin Increase in Early Identification of Critically Ill Patients at High Risk of Mortality,” Critical Care Medicine, Vol. 34, No. 10, 2006, pp. 2596-2602.
doi:10.1097/01.CCM.0000239116.01855.61
|
[10]
|
C. Pierrakos and J. L. Vincent, “Sepsis Biomarkers: A Review,” Critical Care, Vol. 14, No. 1, 2010, p. R15.
doi:10.1186/cc8872
|
[11]
|
J. C. Singh and N. S. Kekre, “Procalcitonin: A Marker for Renal Parenchymal Infection in Children?” Indian Journal of Urology, Vol. 22, No. 2, 2006, pp. 162-63.
|
[12]
|
S. K. Todi, “Top Stories of 2009,” Indian Journal of Critical Care Medicine, Vol. 14, No. 1, 2010, pp. 3-7.
doi:10.4103/0972-5229.63027
|
[13]
|
U. Sudhir, R. K. Venkatachaliah, T. Anilkumar, M. Yogeshwar Rao and P. Kempegowda, “Significance of Serum Procalcitonin in Sepsis,” Indian Journal of Critical Care Medicine, Vol. 15, No. 1, 2011, pp. 1-5.
doi:10.4103/0972-5229.78214
|
[14]
|
M. Sinha, S. Desai, S. Mantri and A. Kulkarni, “Procalcitonin as an Adjunct Biomarker in Sepsis,” Indian Journal of Anesthesia, Vol. 55, No. 3, 2011, pp. 266-270.
doi:10.4103/0019-5049.82676
|
[15]
|
M. Meisner, “PCT in the Differential Diagnosis of Viral and Bacterial Infections,” In: M. Meisner, Ed., Procalcitonin—A New Innovative Infection Parameter Biochemical and Clinical Aspects, 3rd Edition, Thieme Verlag, Stuttgart, 2000, pp 136-37.
|